港股異動 | 敏實集團(0425.HK)漲4.5% 獲多家機構唱好
格隆匯6月23日丨敏實集團(0425.HK)收復昨日失地,現報22.1港元,漲幅4.49%,最新總市值254.3億港元。中金昨日發研報指,目前公司股價對應2021年10.4倍P/E,股價回調提供低吸機會,維持2020、2021年盈利預測不變,維持跑贏行業評級,基於估值切換,上調目標價8.5%到28港元。大和研報指,敏實集團與海拉(HELLA)合作開發雷達罩相關產品,加上鋁電池盒業務有望實現收入增長。該行重申其“買入”評級,目標價由25港元上調16%至29港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.